Distribution of phosphorylated protein kinase C alpha in goldfish retinal bipolar synaptic terminals: control by state of adaptation and pharmacological treatment.
Protein kinase C (PKC) is a signalling enzyme critically involved in many aspects of synaptic plasticity. In cyprinid retinae, the PKC alpha isoform is localized in a subpopulation of depolarizing bipolar cells that show adaptation-related morphological changes of their axon terminals. We have studied the subcellular localization of phosphorylated PKC alpha (pPKC alpha) in retinae under various conditions by immunohistochemistry with a phosphospecific antibody. In dark-adapted retinae, pPKC alpha immunoreactivity is weak in the cytoplasm of synaptic terminals, labelling being predominantly associated with the membrane compartment. In light-adapted cells, immunoreactivity is diffusely distributed throughout the terminal. Western blot analysis has revealed a reduction of pPKC alpha immunoreactivity in cytosolic fractions of homogenized dark-adapted retinae compared with light-adapted retinae. Pharmacological experiments with the isoform-specific PKC blocker Goe6976 have shown that inhibition of the enzyme influences immunolabelling for pPKC alpha, mimicking the effects of light on the subcellular distribution of immunoreactivity. Our findings suggest that the state of adaptation modifies the subcellular localization of a signalling molecule (PKC alpha) at the ribbon-type synaptic complex. We propose that changes in the subcellular distribution of PKC alpha immunoreactivity might be one component regulating the strength of the signal transfer of the bipolar cell terminal.
Behrens
Uwe D
UD
Anatomisches Institut, Oesterbergstrasse 3, 72074, Tübingen, Germany. uwed.behrens@web.de
Borde
Johannes
J
Mack
Andreas F
AF
Wagner
Hans-Joachim
HJ
D000221:Adaptation, Ocular / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D002227:Carbazoles / Q000494:pharmacology; D003600:Cytosol / Q000737:chemistry / Q000378:metabolism; D003623:Dark Adaptation / Q000187:drug effects / Q000502:physiology; D006054:Goldfish / Q000378:metabolism*; D007211:Indoles / Q000494:pharmacology; D010766:Phosphorylation; D017729:Presynaptic Terminals / Q000737:chemistry / Q000378:metabolism*; D051571:Protein Kinase C-alpha / Q000032:analysis / Q000037:antagonists & inhibitors / Q000378:metabolism*; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D012160:Retina / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D051245:Retinal Bipolar Cells / Q000737:chemistry / Q000378:metabolism*
D002227:Carbazoles; D007211:Indoles; D047428:Protein Kinase Inhibitors; C081021:Go 6976; D051571:Protein Kinase C-alpha